Hazlett, Burt & Watson’s AngioDynamics ANGO Stock Holding History

Hazlett, Burt & Watson’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2K	Hold	157	–	–	﹤0.01%	844
2025 Q4	$2K	Hold	157	–	–	﹤0.01%	853
2025 Q3	$2K	Buy	+157	New	+$1.51K	﹤0.01%	802

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Hazlett, Burt & Watson's ANGO Position: Q1 2026 in Review

Hazlett, Burt & Watson held its AngioDynamics (ANGO) position steady in Q1 2026 at 157 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Hazlett, Burt & Watson first reported a position in ANGO in Q3 2025 and has held it in 3 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Hazlett, Burt & Watson held 157 shares of AngioDynamics worth $2K as of Q1 2026.
Hazlett, Burt & Watson left its AngioDynamics share count unchanged in Q1 2026.
AngioDynamics made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #844 holding.
Hazlett, Burt & Watson first reported a position in AngioDynamics in Q3 2025 and has held it in 3 quarters since.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.